Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.
作者信息
Day R M, Carroll F D
出版信息
Trans Am Ophthalmol Soc. 1967;65:41-51.
Abstract
摘要
相似文献
1
Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.皮质类固醇治疗与甲状腺功能障碍相关的视神经受累
Trans Am Ophthalmol Soc. 1967;65:41-51.
2
Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.皮质类固醇治疗与甲状腺功能障碍相关的视神经受累
Arch Ophthalmol. 1968 Mar;79(3):279-82. doi: 10.1001/archopht.1968.03850040281009.
3
Optic neuropathy of Graves disease, hyperthyroidism, and ocular myasthenia gravis.格雷夫斯病、甲状腺功能亢进症和眼肌型重症肌无力所致的视神经病变。
Arch Ophthalmol. 1973 Aug;90(2):131-2. doi: 10.1001/archopht.1973.01000050133013.
4
[Treatment of Grave's ophthalmopathy with high doses of corticosteroids].[大剂量皮质类固醇治疗格雷夫斯眼病]
Srp Arh Celok Lek. 2000 May-Jun;128(5-6):179-83.
5
Anterior ischemic optic neuropathy in Graves' disease.
J Neuroophthalmol. 1994 Sep;14(3):170-4.
6
[Treatment of hyperthyroid atrial fibrillation associated with Graves disease by prednisone].[泼尼松治疗格雷夫斯病伴发的甲状腺功能亢进性心房颤动]
Zhonghua Yi Xue Za Zhi. 2002 Jun 25;82(12):810-2.
7
[Compressive optic neuropathy and dysthyroidal ophthalmopathy. Therapeutic approach].[压迫性视神经病变与甲状腺功能异常性眼病。治疗方法]
Bull Soc Ophtalmol Fr. 1988 Feb;88(2):201-3, 206.
8
Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.糖皮质激素治疗的格雷夫斯眼病患者血清Th1和Th2型细胞因子水平变化
Horm Metab Res. 2001 Dec;33(12):739-43. doi: 10.1055/s-2001-19135.
9
Recovery from pancytopaenia and liver dysfunction after administration of propylthiouracil for Graves' disease.丙硫氧嘧啶治疗格雷夫斯病后全血细胞减少和肝功能障碍的恢复情况
N Z Med J. 2005 Aug 12;118(1220):U1615.
10
An informative case of Graves' disease with implications for schizophrenia.一例具有精神分裂症相关意义的格雷夫斯病信息性病例。
J Clin Lab Immunol. 2004;53:13-25.
引用本文的文献
1
A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy.静脉注射甲基强的松龙治疗甲状腺相关眼病性视神经病变的单中心疗效分析及相关因素。
BMC Ophthalmol. 2023 Jan 23;23(1):32. doi: 10.1186/s12886-023-02789-5.
2
Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy.甲状腺相关眼病性视神经病变患者治疗后的临床特征及视力预后
Korean J Ophthalmol. 2012 Apr;26(2):73-9. doi: 10.3341/kjo.2012.26.2.73. Epub 2012 Mar 22.
3
Reversal of dysthyroid optic neuropathy following orbital fat decompression.眼眶脂肪减压术后甲状腺相关眼病性视神经病变的逆转
Br J Ophthalmol. 2000 Jun;84(6):600-5. doi: 10.1136/bjo.84.6.600.
4
Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.格雷夫斯眼病疾病活动评估的临床标准：一种新方法。
Br J Ophthalmol. 1989 Aug;73(8):639-44. doi: 10.1136/bjo.73.8.639.
本文引用的文献
1
The present status of ACTH and cortisone in clinical ophthalmology.促肾上腺皮质激素和可的松在临床眼科中的现状
Am J Ophthalmol. 1951 Jul;34(7):945-60. doi: 10.1016/0002-9394(51)91162-2.
2
Adrenocorticotropic hormone ACTH and cortisone in ophthalmology; report of cases.
AMA Arch Ophthalmol. 1951 Mar;45(3):301-16. doi: 10.1001/archopht.1951.01700010307005.
3
The effect of cortisone and adrenocorticotrophic hormone on the concentration of circulating antibody.可的松和促肾上腺皮质激素对循环抗体浓度的影响。
J Exp Med. 1951 Jan;93(1):37-48. doi: 10.1084/jem.93.1.37.
4
Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease.格雷夫斯病严重浸润性眼病的肾上腺类固醇治疗
Am J Med. 1963 Jun;34:786-95. doi: 10.1016/0002-9343(63)90087-1.
5
Visual changes in progressive exophthalmos.进行性眼球突出的视觉变化。
AMA Arch Ophthalmol. 1955 Jan;53(1):94-104. doi: 10.1001/archopht.1955.00930010096010.
6
Temporal decompression of the orbit for thyroid exophthalmos.甲状腺性突眼的眼眶颞部减压术。
Am J Ophthalmol. 1966 Dec;62(6):1089-98. doi: 10.1016/0002-9394(66)92558-x.
7
Dysthyroid exophthalmos. Palliation by lateral orbital decompression.甲状腺功能异常性突眼。经外侧眼眶减压缓解。
Arch Ophthalmol. 1966 Aug;76(2):205-10. doi: 10.1001/archopht.1966.03850010207010.
8
Methylprednisolone in the treatment of exophthalmos.甲基强的松龙治疗突眼症
Lancet. 1966 Apr 30;1(7444):958-60. doi: 10.1016/s0140-6736(66)90954-8.
Zotero 插件